{"id":"https://openalex.org/W2372009398","doi":null,"title":"A randomized, double blind, double dummy parallel controlled study in the female first-ondet schizophrenia treated with aripiprazole and quetiapine","display_name":"A randomized, double blind, double dummy parallel controlled study in the female first-ondet schizophrenia treated with aripiprazole and quetiapine","publication_year":2006,"publication_date":"2006-01-01","ids":{"openalex":"https://openalex.org/W2372009398","mag":"2372009398"},"language":"en","primary_location":{"id":"mag:2372009398","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-JBJS200603011.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764662714","display_name":"Nervous Diseases and Mental Health","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Nervous Diseases and Mental Health","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009298530","display_name":"Wei Sheng-zhon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Wei Sheng-zhon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5009298530"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.29781746,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9449999928474426},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":1.0},{"id":"https://openalex.org/keywords/first-episode-schizophrenia","display_name":"first-episode schizophrenia","score":0.8859999775886536},{"id":"https://openalex.org/keywords/female-patients","display_name":"female patients","score":0.7329999804496765},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.9210000038146973},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.8009999990463257},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.7360000014305115},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.875},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.6420000195503235},{"id":"https://openalex.org/keywords/amenorrhea-galactorrhea-syndrome","display_name":"amenorrhea-galactorrhea syndrome","score":0.8980000019073486},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8299999833106995},{"id":"https://openalex.org/keywords/positive-and-negative-syndrome-scale","display_name":"PANSS","score":0.4440000057220459},{"id":"https://openalex.org/keywords/tess","display_name":"TESS","score":0.7900000214576721},{"id":"https://openalex.org/keywords/clinical-global-impression-scale","display_name":"Clinical Global Impression Scale","score":0.7960000038146973}],"concepts":[{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.94486403465271},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.8863801956176758},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5791774988174438},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5624977946281433},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5491032600402832},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5015420913696289},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.47048261761665344},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.46122533082962036},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.4596398174762726},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.444004625082016},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4383848309516907},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.40411192178726196},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.38105738162994385},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.13464748859405518},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.060479313135147095},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2372009398","doi":null,"is_oa":false,"landing_page_url":"https://en.cnki.com.cn/Article_en/CJFDTOTAL-JBJS200603011.htm","pdf_url":null,"source":{"id":"https://openalex.org/S2764662714","display_name":"Nervous Diseases and Mental Health","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Nervous Diseases and Mental Health","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2349845785","https://openalex.org/W2363886953","https://openalex.org/W1562262302","https://openalex.org/W2375608525","https://openalex.org/W2351656822","https://openalex.org/W2373268711","https://openalex.org/W2385256580","https://openalex.org/W2372471325","https://openalex.org/W2388367481","https://openalex.org/W3032818825"],"abstract_inverted_index":{"Objective":[0],"To":[1],"compare":[2],"efficacy":[3,79,107,115],"and":[4,8,45,62,69,80,85,113,122,125,151,175,192,243,270,280],"safety":[5],"of":[6,13,89,109,143,190,211,214,266,286,298],"aripiprazole":[7,54,110,149,166,196,226,257],"quetiapine":[9,56,128,154,170,203,219,262],"in":[10,38,102,127,148,153,165,169,195,202,218,225,274,284],"the":[11,32,41,87,114,136,184,264,295],"treatment":[12,265,285],"female":[14,96,267,287,299],"first-ondet":[15],"schizophrenia.":[16],"Methods":[17],"The":[18,60,105,140,161,188,209,253],"randomized,":[19],"Double":[20],"blind,":[21],"double":[22],"dummy":[23],"parallel":[24],"controlled":[25],"was":[26,111,117,123,131,146,172,179,198,221],"designed":[27],"for":[28,57,263],"this":[29,103],"study.":[30,104],"All":[31],"cases":[33],"were":[34,51,75,100],"diagnosed":[35],"as":[36,259,261],"schizophrenia":[37,98,269,301],"accordance":[39],"with":[40,53],"CCMD-3":[42],"diagnosis":[43],"standard":[44],"randomized":[46],"into":[47],"two":[48,137,185],"groups":[49,138,186],"which":[50],"treated":[52],"or":[55,168,216],"8":[58,120],"weeks.":[59],"Positive":[61],"Negative":[63],"Syndrome":[64],"Scale(PANSS),":[65],"Clinical":[66],"Global":[67],"Impression(CGI)":[68],"Treatment":[70],"Emergent":[71],"Side":[72],"effect":[73,145,163],"Scale(TESS)":[74],"used":[76],"to":[77,293],"evaluate":[78],"adverse":[81,144,162],"effects":[82,273],"respectively":[83],"before":[84],"at":[86],"ends":[88],"2,4,8":[90],"weeks":[91,121],"treatment.":[92,251],"Results":[93],"101":[94],"adult":[95],"first-onset":[97,268,288,300],"patients":[99],"recruited":[101],"significant":[106,133,158,181],"rates":[108],"66.0%":[112],"rate":[116,142,189,210],"92%":[118],"after":[119],"64.7%":[124],"92.2%":[126],"group.":[129],"There":[130,178],"no":[132,180],"difference":[134,159,182],"between":[135,183],"(P0.05).":[139,160,187],"incidence":[141],"34.00%":[147],"group":[150,167,171,197,220],"35.29%":[152],"group,":[155],"without":[156],"any":[157],"either":[164],"drowsiness(16.00%\u223619.61%),":[173],"dizziness":[174],"faint":[176],"(12%\u223613.73%).":[177],"nausea":[191],"vomiting,":[193],"headache":[194],"higher":[199,222],"than":[200,223],"that":[201,224,256],"group(14.00%\u22361.96%":[204],"P0.05,":[205,228],"18.00%\u22361.96%":[206],"P":[207],"0.01).":[208],"dry":[212],"mouth,decrease":[213],"appetite":[215],"anorexia":[217],"group(15.69%\u22362.00%":[227],"15.69%\u22362.00%":[229],"P0.05).":[230],"Both":[231],"drugs":[232,283],"showed":[233],"low":[234],"extrapyramidal":[235],"symptoms,":[236],"less":[237,240],"endocrine":[238],"change,":[239],"weight":[241],"gain":[242],"has":[244],"not":[245],"found":[246],"amenorrhea":[247],"galactorrhea":[248],"syndrome":[249],"during":[250],"Conclusions":[252],"results":[254],"suggest":[255],"is":[258],"effective":[260,279],"fewer":[271],"side":[272],"them.":[275],"They":[276,290],"both":[277],"are":[278,291],"safe":[281],"antipsychotic":[282],"sihizophrenia.":[289],"beneficial":[292],"improve":[294],"therapeutic":[296],"compliance":[297],"patients.":[302]},"counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}